Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Jan 2026 for Larimar Therapeutics, Inc..
Filing timeline
BuySaleGopi Shankar
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gopi Shankar: trading record in brief
All filings by Gopi Shankar on record concern Larimar Therapeutics, Inc. The record holds 4 filings, for trades running from 7 December 2023 to 26 January 2026.
No open-market sale appears; the market trades are 1 purchase worth €17k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants.
The newest entry dates from 27 January 2026: a share grant, in Larimar Therapeutics, Inc. The latest purchase dates back some time: it was published 1,051 days ago, on 8 December 2023. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gopi Shankar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
25,637 shares0Common StockSEC:0001193125-26-024833:0
23,306 shares0Common StockSEC:0001062993-25-001080:0
22,500 shares0Common StockSEC:0001062993-24-001086:0
5,000 shares@ US$3.7323100.0% of flowCommon StockSEC:0001062993-23-022200:0
Canonical exit: 6 Mar 2024 (T+90)
4 of 4 declarations
